Add like
Add dislike
Add to saved papers

Hip Abductor Weakness and Its Association with New or Worsened Knee Pain: the MOST Study.

OBJECTIVE: Hip abductors, important for controlling pelvic and femoral orientation during gait, may affect knee pain. We evaluated the relation of hip abductor strength to worsened or new onset frequent knee pain (FKP). Given previously noted associations of knee extensor strength with OA in women, we performed sex-specific analyses.

METHODS: We used data from the Multicenter Osteoarthritis Study (MOST). Hip abductor and knee extensor strength was measured. Knee pain was assessed using the WOMAC questionnaire and a question about FKP at baseline (144-month visit), and 8, 16 and 24 months thereafter. Knee pain outcomes were (1) worsened knee pain (2-point increase in WOMAC pain) and (2) incident FKP (answering 'yes' to the FKP question among those without FKP at baseline). Leg-specific analyses tested hip abductor strength as a risk factor for worsened and new FKP, adjusting for potential covariates. Additionally, we stratified by knee extensor strength (high vs. low).

RESULTS: Among women, compared to the highest quartile of hip abductor strength, the lowest quartile had 1.7 (95%CI 1.1, 2.6) times the odds of worsened knee pain; significant associations were limited to women with high knee extensor strength (OR=2.0 (1.1,3.5)). We found no relation of abductor strength to worsening knee pain in men or with incident FKP in men or women.

CONCLUSION: Hip abductor weakness was associated with worsening knee pain in women with strong knee extensors, but not with incident frequent knee pain in men or women. Knee extensor strength may be necessary, but not sufficient, to prevent pain worsening.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app